Skip to main content

Illumina Sells BeadLab Station to Mayo Clinic

NEW YORK, Jan. 19 (GenomeWeb News) - Mayo Clinic will purchase a BeadLab genotyping system from Illumina to study cancer and other complex diseases, the company said today.

 

Mayo researchers plan to use the station initially mainly for genomic studies of cancer and various neuropsychiatric and cardiovascular disorders.

 

The system, which will be installed at Mayo's Rochester, Minn., location and be able to produce one million genotypes per day, will be available to investigators at all three Mayo Clinic sites. The other two sites are located in Jacksonville, Fla., and Scottsdale, Ariz.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.